Effects of nutritional status on serum fetuin-A level

References

• Al-Regaiey, K. 2016. The effects of calorie restriction on aging: A brief review. European Review for Medical and Pharmacological Sciences 20 (11):2468–73.
   PubMed Web of Science ®Google Scholar
• Ammon, H. P., and M. A. Wahl. 1991. Pharmacology of Curcuma longa. Planta Medica 57 (1):1–7. doi: 10.1055/s-2006-960004.
   PubMed Web of Science ®Google Scholar
• An, W. S., S. M. Lee, Y. K. Son, S. E. Kim, K. H. Kim, J. Y. Han, H. R. Bae, S. H. Rha, and Y. Park. 2012. Omega-3 fatty acid supplementation increases 1, 25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutrition Research 32 (7):495–502. doi: 10.1016/j.nutres.2012.06.005.
   PubMed Web of Science ®Google Scholar
• Andersen, G., K. S. Burgdorf, T. Sparsø, K. Borch-Johnsen, T. Jørgensen, T. Hansen, and O. Pedersen. 2008. AHSG tagSNPs associate with type 2 diabetes and dyslipidemia: Studies of metabolic traits in 7,683 Danish whites. Diabetes 57 (5):1427–32.
   PubMed Web of Science ®Google Scholar
• Archer, E., C. J. Lavie, and J. O. Hill. 2018. The contributions of ‘diet’, ‘genes’, and physical activity to the etiology of obesity: Contrary evidence and consilience. Progress in Cardiovascular Diseases 61 (2):89–102. doi: 10.1016/j.pcad.2018.06.002.
   PubMed Web of Science ®Google Scholar
• Auberger, P., L. Falquerho, J. O. Contreres, G. Pages, G. Le Cam, B. Rossi, and A. Le Cam. 1989. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58 (4):631–40. doi: 10.1016/0092-8674(89)90098-6.
   PubMed Web of Science ®Google Scholar
• Baliunas, D. O., B. J. Taylor, H. Irving, M. Roerecke, J. Patra, S. Mohapatra, and J. Rehm. 2009. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 32 (11):2123–32. doi: 10.2337/dc09-0227.
   PubMed Web of Science ®Google Scholar
• Blumenthal, J. B., A. Gitterman, A. S. Ryan, and S. J. Prior. 2017. Effects of exercise training and weight loss on plasma fetuin-A levels and insulin sensitivity in overweight older men. Journal of Diabetes Research 2017:1. doi:10.1155/2017/1492581.
   Google Scholar
• Brix, J. M., H. Stingl, F. HöLlerl, G. H. Schernthaner, H.-P. Kopp, and G. Schernthaner. 2010. Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. The Journal of Clinical Endocrinology & Metabolism 95 (11):4877–81. doi: 10.1210/jc.2010-0148.
   PubMed Web of Science ®Google Scholar
• Brown, W. M., N. R. Saunders, K. Møllgård, and K. M. Dziegielewska. 1992. Fetuin – An old friend revisited. Bioessays: News and Reviews in Molecular, Cellular and Developmental Biology 14 (11):749–55. doi: 10.1002/bies.950141105.
   PubMed Web of Science ®Google Scholar
• Carracedo, M., and M. Bäck. 2018. Fetuin A in aortic stenosis and valve calcification: Not crystal clear. International Journal of Cardiology 265:77–8. doi: 10.1016/j.ijcard.2018.04.115.
   PubMed Web of Science ®Google Scholar
• Choi, K. M., K. A. Han, H. J. Ahn, S. Y. Lee, S. Y. Hwang, B. H. Kim, H. C. Hong, H. Y. Choi, S. J. Yang, H. J. Yoo, et al. 2013. The effects of caloric restriction on fetuin‐A and cardiovascular risk factors in rats and humans: A randomized controlled trial. Clinical Endocrinology 79 (3):356–63. doi: 10.1111/cen.12076.
   PubMed Web of Science ®Google Scholar
• Dahlman, I., P. Eriksson, M. Kaaman, H. Jiao, C. Lindgren, J. Kere, and P. Arner. 2004. α 2-Heremans–Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 47 (11):974–1979.
   Web of Science ®Google Scholar
• Dalamaga, M., K. Karmaniolas, J. Chamberland, A. Nikolaidou, A. Lekka, A. Dionyssiou-Asteriou, and C. S. Mantzoros. 2013. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Metabolism 62 (12):1830–9. doi: 10.1016/j.metabol.2013.09.007.
   PubMed Web of Science ®Google Scholar
• Dasgupta, S., S. Bhattacharya, A. Biswas, S. S. Majumdar, S. Mukhopadhyay, S. Ray, and S. Bhattacharya. 2010. NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochemical Journal 429 (3):451–62. doi: 10.1042/BJ20100330.
   PubMedGoogle Scholar
• Demetriou, M., C. Binkert, B. Sukhu, H. C. Tenenbaum, and J. W. Dennis. 1996. Fetuin/α2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist. Journal of Biological Chemistry 271 (22):12755–61. doi: 10.1074/jbc.271.22.12755.
   PubMed Web of Science ®Google Scholar
• Di Minno, A., M. Zanobini, V. A. Myasoedova, V. Valerio, P. Songia, M. Saccocci, M. N. D. Di Minno, E. Tremoli, and P. Poggio. 2017. Could circulating fetuin A be a biomarker of aortic valve stenosis? International Journal of Cardiology 249:426–30. doi: 10.1016/j.ijcard.2017.05.040.
   PubMed Web of Science ®Google Scholar
• Dickson, J., A. Liese, C. Lorenzo, S. Haffner, S. Watkins, S. Hamren, J. K. Stiles, L. E. Wagenknecht, and A. Hanley. 2015. Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. BMC Gastroenterology 15 (1):88.
   PubMedGoogle Scholar
• Fisher, E., N. Stefan, K. Saar, D. Drogan, M. B. Schulze, A. Fritsche, H. G. Joost, H. U. Häring, N. Hubner, H. Boeing, and C. Weikert. 2009. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circulation: Cardiovascular Genetics 2 (6):607–13. doi: 10.1161/CIRCGENETICS.109.870410.
   PubMedGoogle Scholar
• Flegal, K. M., M. D. Carroll, B. K. Kit, and C. L. Ogden. 2012. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. Jama 307 (5):491–7. doi: 10.1001/jama.2012.39.
   PubMed Web of Science ®Google Scholar
• Ghaffari, A., M. Rafraf, R. Navekar, B. Sepehri, M. Asghari-Jafarabadi, S.-M. Ghavami, and N. Manafi. 2017. Effects of turmeric on homocysteine and fetuin-A in patients with nonalcoholic fatty liver disease: A randomized double-blind placebo-controlled study. Iranian Red Crescent Medical Journal 19 (4):e43193.
   Web of Science ®Google Scholar
• Grundy, S. M., G. L. Vega, M. E. McGovern, B. R. Tulloch, D. M. Kendall, D. Fitz-Patrick, O. P. Ganda, R. S. Rosenson, J. B. Buse, D. D. Robertson, and J. P. Sheehan. 2002. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: Results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Archives of Internal Medicine 162 (14):1568–76. doi: 10.1001/archinte.162.14.1568.
   PubMedGoogle Scholar
• Guo, V. Y., B. Cao, C. Cai, K. K-y Cheng, and B. M. Y. Cheung. 2018. Fetuin-A levels and risk of type 2 diabetes mellitus: A systematic review and meta-analysis. Acta Diabetologica 55 (1):87–98. doi: 10.1007/s00592-017-1068-9.
   PubMed Web of Science ®Google Scholar
• Guo, V. Y., B. Cao, C. K. H. Wong, and E. Y. T. Yu. 2017. The association between daytime napping and risk of diabetes: A systematic review and meta-analysis of observational studies. Sleep Medicine 37:105–12. doi: 10.1016/j.sleep.2017.01.018.
   PubMed Web of Science ®Google Scholar
• Haukeland, J. W., T. B. Dahl, A. Yndestad, I. P. Gladhaug, E. M. Løberg, T. Haaland, Z. Konopski, C. Wium, E. T. Aasheim, O. E. Johansen, et al. 2012. Fetuin A in nonalcoholic fatty liver disease: In vivo and in vitro studies. European Journal of Endocrinology 166 (3):503–10. doi: 10.1530/EJE-11-0864.
   PubMed Web of Science ®Google Scholar
• Hennige, A. M., H. Staiger, C. Wicke, F. Machicao, A. Fritsche, H.-U. Häring, and N. Stefan. 2008. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 3 (3):765.
   Web of Science ®Google Scholar
• Hwang, J. J., B. Thakkar, J. P. Chamberland, and C. S. Mantzoros. 2014. Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration. Metabolism: Clinical and Experimental 63 (6):754–9. doi: 10.1016/j.metabol.2014.02.006.
   PubMed Web of Science ®Google Scholar
• Icer, M. A., M. Gezmen-Karadag, and S. Sozen. 2018. Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis? Clinical Biochemistry 60:38–43. doi: 10.1016/j.clinbiochem.2018.08.001.
   PubMed Web of Science ®Google Scholar
• İçer, M. A., and M. Gezmen-Karadağ. 2018. The multiple functions and mechanisms of osteopontin. Clinical Biochemistry 59:17–24.
   PubMed Web of Science ®Google Scholar
• Ix, J. H., G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley. 2007. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation 115 (19):2533–9. doi: 10.1161/CIRCULATIONAHA.106.682450.
   PubMed Web of Science ®Google Scholar
• Ix, J. H., and K. Sharma. 2010. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: The roles of fetuin-A, adiponectin, and AMPK. Journal of the American Society of Nephrology 21 (3):406–12.
   PubMed Web of Science ®Google Scholar
• Ix, J. H., M. G. Shlipak, V. M. Brandenburg, S. Ali, M. Ketteler, and M. A. Whooley. 2006. Association between human fetuin-A and the metabolic syndrome: Data from the Heart and Soul Study. Circulation 113 (14):1760–7. doi: 10.1161/CIRCULATIONAHA.105.588723.
   PubMed Web of Science ®Google Scholar
• Ix, J. H., C. L. Wassel, G. M. Chertow, A. Koster, K. C. Johnson, F. A. Tylavsky, J. A. Cauley, S. R. Cummings, T. B. Harris, and M. G. Shlipak. 2009. Fetuin-A and change in body composition in older persons. The Journal of Clinical Endocrinology & Metabolism 94 (11):4492–8. doi: 10.1210/jc.2009-0916.
   PubMed Web of Science ®Google Scholar
• Jacob, A., R. Wu, M. Zhou, and P. Wang. 2007. Mechanism of the anti-inflammatory effect of curcumin: PPAR-γ activation. PPAR Research 2007:89369.
   PubMed Web of Science ®Google Scholar
• Jacobs, S., J. Kröger, A. Floegel, H. Boeing, D. Drogan, T. Pischon, A. Fritsche, C. Prehn, J. Adamski, B. Isermann, et al. 2014. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. The American Journal of Clinical Nutrition 100 (3):891–900. doi: 10.3945/ajcn.113.080317.
   PubMed Web of Science ®Google Scholar
• Jang, E.-M., M.-S. Choi, U. J. Jung, M.-J. Kim, H.-J. Kim, S.-M. Jeon, S.-K. Shin, C.-N. Seong, and M.-K. Lee. 2008. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat–fed hamsters. Metabolism 57 (11):1576–83. doi: 10.1016/j.metabol.2008.06.014.
   PubMed Web of Science ®Google Scholar
• Joosten, M. M., I. C. Schrieks, and H. F. Hendriks. 2014. Effect of moderate alcohol consumption on fetuin-A levels in men and women: Post-hoc analyses of three open-label randomized crossover trials. Diabetology & Metabolic Syndrome 6 (1):24.
   PubMedGoogle Scholar
• Kaden, J. J., J. O. Reinöhl, B. Blesch, M. Brueckmann, D. Haghi, M. Borggrefe, F. Schmitz, S. Klomfass, and J. R. Ortlepp. 2007. Systemic and local levels of fetuin-A in calcific aortic valve stenosis. International Journal of Molecular Medicine 20 (2):193–7.
   PubMed Web of Science ®Google Scholar
• Kalabay, L., K. Cseh, A. Pajor, É. Baranyi, G. M. Csakany, Z. Melczer, G. Speer, M. Kovacs, G. Siller, I. Karadi, and G. Winkler. 2002. Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. European Journal of Endocrinology 147 (2):243–248. doi: 10.1530/eje.0.1470243.
   PubMed Web of Science ®Google Scholar
• Kaushik, S. V., E. P. Plaisance, T. Kim, E. Y. Huang, A. J. Mahurin, P. W. Grandjean, and S. T. Mathews. 2009. Extended‐release niacin decreases serum fetuin‐a concentrations in individuals with metabolic syndrome. Diabetes/Metabolism Research and Reviews 25 (5):427–34. doi: 10.1002/dmrr.967.
   PubMed Web of Science ®Google Scholar
• Kawano, J., and R. Arora. 2009. The role of adiponectin in obesity, diabetes, and cardiovascular disease. Journal of the Cardiometabolic Syndrome 4 (1):44–9. doi: 10.1111/j.1559-4572.2008.00030.x.
   PubMedGoogle Scholar
• Ketteler, M., P. Bongartz, R. Westenfeld, J. E. Wildberger, A. H. Mahnken, R. Böhm, T. Metzger, C. Wanner, W. Jahnen-Dechent, and J. Floege. 2003. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. The Lancet 361 (9360):827–33. doi: 10.1016/S0140-6736(03)12710-9.
   PubMed Web of Science ®Google Scholar
• Lee, H. J., Y. Lim, and S. J. Yang. 2015. Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitro. The Journal of Nutritional Biochemistry 26 (11):1254–60. doi: 10.1016/j.jnutbio.2015.06.001.
   PubMed Web of Science ®Google Scholar
• Lee, S., F. Norheim, H. L. Gulseth, T. M. Langleite, K. J. Kolnes, D. S. Tangen, H., K. Stadheim, G., D. Gilfillan, T. Holen, K., I. Birkeland., et al. 2017. Interaction between plasma fetuin‐A and free fatty acids predicts changes in insulin sensitivity in response to long‐term exercise. Physiological Reports 5 (5):e13183.
   PubMed Web of Science ®Google Scholar
• Ley, S. H., Q. Sun, M. C. Jimenez, K. M. Rexrode, J. E. Manson, M. K. Jensen, E. B. Rimm, and F. B. Hu. 2014. Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women. Diabetologia 57 (1):93–101. doi: 10.1007/s00125-013-3077-8.
   PubMed Web of Science ®Google Scholar
• Liangpunsakul, S., and N. Chalasani. 2012. What should we recommend to our patients with NAFLD regarding alcohol use? The American Journal of Gastroenterology 107 (7):976doi: 10.1038/ajg.2012.20.
   PubMed Web of Science ®Google Scholar
• Ma, Z., A. B. Parris, E. W. Howard, Y. Shi, S. Yang, Y. Jiang, L. Kong, and X. Yang. 2018. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues. Carcinogenesis 39 (10):1264–73. doi: 10.1093/carcin/bgy096.
   PubMed Web of Science ®Google Scholar
• Mahan, L. K., and J. L. Raymond. 2016. Krause’s food & the nutrition care process-e-book. Oxford, UK: Elsevier Health Sciences.
   Google Scholar
• Manjunatha, H., and K. Srinivasan. 2007. Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats. Canadian Journal of Physiology and Pharmacology 85 (6):588–96. doi: 10.1139/y07-044.
   PubMed Web of Science ®Google Scholar
• Mathews, S. T., S. Rakhade, X. Zhou, G. C. Parker, D. V. Coscina, and G. Grunberger. 2006. Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochemical and Biophysical Research Communications 350 (2):437–43. doi: 10.1016/j.bbrc.2006.09.071.
   PubMed Web of Science ®Google Scholar
• Mathews, S. T., G. P. Singh, M. Ranalletta, V. J. Cintron, X. Qiang, A. S. Goustin, K. C. Jen, M. Charron, J. W. Jahnen-Dechent, and G. Grunberger. 2002. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51 (8):2450–8. doi: 10.2337/diabetes.51.8.2450.
   PubMed Web of Science ®Google Scholar
• Miura, Y., Y. Iwazu, K. Shiizaki, T. Akimoto, K. Kotani, M. Kurabayashi, H. Kurosu, and M. Kuro-O. 2018. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease. Scientific Reports 8 (1):1256.
   PubMedGoogle Scholar
• Moe, S. M., M. Reslerova, M. Ketteler, K. O'Neill, D. Duan, J. Koczman, R. Westenfeld, W. Jahnen-Dechent, and N. X. Chen. 2005. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney International 67 (6):2295–304. doi: 10.1111/j.1523-1755.2005.00333.x.
   PubMed Web of Science ®Google Scholar
• Mori, K., M. Emoto, H. Yokoyama, T. Araki, M. Teramura, H. Koyama, T. Shoji, M. Inaba, and Y. Nishizawa. 2006. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 29 (2):468. doi: 10.2337/diacare.29.02.06.dc05-1484.
   PubMed Web of Science ®Google Scholar
• Mukhuty, A., C. Fouzder, S. Mukherjee, C. Malick, S. Mukhopadhyay, S. Bhattacharya, and R. Kundu. 2017. Palmitate induced Fetuin-A secretion from pancreatic β-cells adversely affects its function and elicits inflammation. Biochemical and Biophysical Research Communications 491 (4):1118–1124. doi: 10.1016/j.bbrc.2017.08.022.
   PubMed Web of Science ®Google Scholar
• Nafakhi, H., H. A. Al-Nafakh, and A. A. Al-Mosawi. 2016. Aortic root calcification: A possible imaging biomarker of coronary atherosclerosis. Pulse 3 (3-4):167–171. doi: 10.1159/000442762.
   PubMed Web of Science ®Google Scholar
• Nawratil, P., S. Lenzen, J. Kellermann, H. Haupt, T. Schinke, W. Müller-Esterl, and W. Jahnen-Dechent. 1996. Limited proteolysis of human α2-HS glycoprotein/fetuin. Evidence that a chymotryptic activity can release the connecting peptide. Journal of Biological Chemistry 271 (49):31735–31741. doi: 10.1074/jbc.271.49.31735.
   PubMed Web of Science ®Google Scholar
• Nikhra, V. 2018. Cardiovascular disease, obesity, MetS, T2DM and aging, and benefits of calorie restriction and calorie restriction mimetics. Cardiology Today 22 (5):158–67.
   Google Scholar
• Nimptsch, K., J. Janke, T. Pischon, and J. Linseisen. 2015. Association between dietary factors and plasma fetuin-A concentrations in the general population. British Journal of Nutrition 114 (8):1278–1285. doi: 10.1017/S0007114515002639.
   PubMed Web of Science ®Google Scholar
• Ochi, A., K. Mori, M. Emoto, S. Nakatani, T. Morioka, K. Motoyama, S. Fukumoto, Y. Imanishi, H. Koyama, E. Ishimura, and M. Inaba. 2014. Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression. PLoS One 9 (2):e88704. doi: 10.1371/journal.pone.0088704.
   PubMed Web of Science ®Google Scholar
• Ochieng, J., G. Nangami, A. Sakwe, C. Moye, J. Alvarez, D. Whalen, P. Thomas, and P. Lammers. 2018. Impact of fetuin-A (AHSG) on tumor progression and type 2 diabetes. International Journal of Molecular Sciences 19 (8):2211. doi: 10.3390/ijms19082211.
   PubMed Web of Science ®Google Scholar
• Ogden, C. L., M. D. Carroll, B. K. Kit, and K. M. Flegal. 2014. Prevalence of childhood and adult obesity in the United States, 2011–2012. Jama 311 (8):806–814. doi: 10.1001/jama.2014.732.
   PubMed Web of Science ®Google Scholar
• Okamoto, T., C. Tsutaya, S. Hatakeyama, S. Konishi, K. Okita, Y. Tanaka, K. Imanishi, T. Takashima, F. Saitoh, T. Suzuki, and C. Ohyama. 2018. Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: A cross-sectional study. International Urology and Nephrology 50 (9):1713–1720. doi: 10.1007/s11255-018-1957-z.
   PubMed Web of Science ®Google Scholar
• Öner-İyidoğan, Y., H. Koçak, M. Seyidhanoğlu, F. Gürdöl, A. Gülçubuk, F. Yildirim, A. Çevik, and M. Uysal. 2013. Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. Journal of Physiology and Biochemistry 69 (4):677–686. doi: 10.1007/s13105-013-0244-9.
   PubMed Web of Science ®Google Scholar
• Pal, D., S. Dasgupta, R. Kundu, S. Maitra, G. Das, S. Mukhopadhyay, S. Ray, S. S. Majumdar, and S. Bhattacharya. 2012. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine 18 (8):2851.
   Web of Science ®Google Scholar
• Pedersen, K. O. 1944. Fetuin, a new globulin isolated from serum. Nature 154 (3914):575. doi: 10.1038/154575a0.
   Google Scholar
• Pereira, M. A., D. R. Jacobs, Jr., L. Van Horn, M. L. Slattery, A. I. Kartashov, and D. S. Ludwig. 2002. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: The CARDIA study. Jama 287 (16):2081–2089. doi: 10.1001/jama.287.16.2081.
   PubMed Web of Science ®Google Scholar
• Price, P. A., and J. E. Lim. 2003. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. Journal of Biological Chemistry 278 (24):22144–22152. doi: 10.1074/jbc.M300744200.
   PubMed Web of Science ®Google Scholar
• Reinehr, T., and C. L. Roth. 2008. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. The Journal of Clinical Endocrinology & Metabolism 93 (11):4479–4485. doi: 10.1210/jc.2008-1505.
   PubMed Web of Science ®Google Scholar
• Roshanzamir, F., M. Miraghajani, M. Mansourian, R. Ghiasvand, and S. M. Safavi. 2017. Association between Healthy Eating Index-2010 and fetuin-A levels in patients with type 2 diabetes: A case-control study. Clinical Nutrition Research 6 (4):296–305. doi: 10.7762/cnr.2017.6.4.296.
   PubMedGoogle Scholar
• Samocha-Bonet, D., C. S. Tam, L. V. Campbell, and L. K. Heilbronn. 2014. Raised circulating fetuin-A after 28-day overfeeding in healthy humans. Diabetes Care 37 (1):e15–e16. doi: 10.2337/dc13-1728.
   PubMed Web of Science ®Google Scholar
• Schäfer, C., A. Heiss, A. Schwarz, R. Westenfeld, M. Ketteler, J. Floege, W. Müller-Esterl, T. Schinke, and W. Jahnen-Dechent. 2003. The serum protein α 2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. The Journal of Clinical Investigation 112 (3):357–366. doi: 10.1172/JCI17202.
   PubMed Web of Science ®Google Scholar
• Schlieper, G., R. Westenfeld, V. Brandenburg, and M. Ketteler. 2007. Vascular calcification in patients with kidney disease: Inhibitors of calcification in blood and urine. Seminars in Dialysis 20 (2):113–121. doi: 10.1111/j.1525-139X.2007.00257.x.
   PubMed Web of Science ®Google Scholar
• Seyithanoğlu, M., Y. Öner-İyidoğan, S. Doğru-Abbasoğlu, S. Tanrıkulu-Küçük, H. Koçak, Ş. Beyhan-Özdaş, and N. Koçak-Toker. 2016. The effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet. Archives of Physiology and Biochemistry 122 (2):94–102. doi: 10.3109/13813455.2015.1120753.
   PubMed Web of Science ®Google Scholar
• Small, A., D. Kiss, J. Giri, S. Anwaruddin, H. Siddiqi, M. Guerraty, J. A. Chirinos, G. Ferrari, and D. J. Rader. 2017. Biomarkers of calcific aortic valve disease. Arteriosclerosis, Thrombosis, and Vascular Biology 37 (4):623–632. doi: 10.1161/ATVBAHA.116.308615.
   PubMed Web of Science ®Google Scholar
• Srinivas, P., A. S. Wagner, L. V. Reddy, D. Deutsch, M. A. Leon, A. S. Goustin, and G. Grunberger. 1993. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Molecular Endocrinology 7 (11):1445–1455. doi: 10.1210/mend.7.11.7906861.
   PubMedGoogle Scholar
• Stefan, N., and H.-U. Häring. 2013. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. [Correspondence]. Nature Medicine 19 (4):394. doi: 10.1038/nm.3116.
   PubMed Web of Science ®Google Scholar
• Stefan, N., A. M. Hennige, H. Staiger, J. Machann, F. Schick, S. M. Kröber, F. Machicao, A. Fritsche, and H.-U. Häring. 2006. α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29 (4):853–857. doi: 10.2337/diacare.29.04.06.dc05-1938.
   PubMed Web of Science ®Google Scholar
• Stenvinkel, P., K. Wang, A. R. Qureshi, J. Axelsson, R. Pecoits-Filho, P. Gao, P. Barany, B. Lindholm, T. Jogestrand, O. Heimberger., et al. 2005. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney International 67 (6):2383–2392. doi: 10.1111/j.1523-1755.2005.00345.x.
   PubMed Web of Science ®Google Scholar
• Swallow, C. J., E. A. Partridge, J. C. Macmillan, T. Tajirian, G. M. DiGuglielmo, K. Hay, M. Szweras, W. Jahnen-Dechent, J. L. Wrana, M. Redston, et al. 2004. α2HS-glycoprotein, an antagonist of transforming growth factor β in vivo, inhibits intestinal tumor progression. Cancer Research 64 (18):6402–6409. doi: 10.1158/0008-5472.CAN-04-1117.
   PubMed Web of Science ®Google Scholar
• Tajirian, T.,. J. W. Dennis, and C. J. Swallow. 2000. Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist. Journal of Cellular Physiology 185 (2):174–183. doi: 10.1002/1097-4652(200011)185:2<174::AID-JCP2>3.0.CO;2-X.
   PubMed Web of Science ®Google Scholar
• Tang, Y., and A. Chen. 2010. Curcumin protects hepatic stellate cells against leptin-induced activation in vitro by accumulating intracellular lipids. Endocrinology 151 (9):4168–4177. doi: 10.1210/en.2010-0191.
   PubMed Web of Science ®Google Scholar
• Thakkinstian, A., L. Chailurkit, D. Warodomwichit, W. Ratanachaiwong, S. Yamwong, S. Chanprasertyothin, J. Attia, P. Sritara, and B. Ongphiphadhanakul. 2014. Causal relationship between body mass index and fetuin‐A level in the Asian population: A bidirectional Mendelian randomization study. Clinical Endocrinology 81 (2):197–203. doi: 10.1111/cen.12303.
   PubMed Web of Science ®Google Scholar
• Vogt, A., U. Kassner, U. Hostalek, and E. Steinhagen-Thiessen. 2007. Correction of low HDL cholesterol to reduce cardiovascular risk: Practical considerations relating to the therapeutic use of prolonged‐release nicotinic acid (Niaspan®). International Journal of Clinical Practice 61 (11):1914–1921. doi: 10.1111/j.1742-1241.2007.01514.x.
   PubMed Web of Science ®Google Scholar
• Wang, A. Y.-M., J. Woo, C. W.-K. Lam, M. Wang, I. H.-S. Chan, P. Gao, S.-F. Lui, P. K.-T. Li, and J. E. Sanderson. 2005. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrology Dialysis Transplantation 20 (8):1676–1685. doi: 10.1093/ndt/gfh891.
   PubMed Web of Science ®Google Scholar
• Wedick, N. M., A. M. Brennan, Q. Sun, F. B. Hu, C. S. Mantzoros, and R. M. van Dam. 2011. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: A randomized controlled trial. Nutrition Journal 10 (1):93.
   PubMedGoogle Scholar
• Weinsier, R. L., G. R. Hunter, A. F. Heini, M. I. Goran, and S. M. Sell. 1998. The etiology of obesity: Relative contribution of metabolic factors, diet, and physical activity. The American Journal of Medicine 105 (2):145–150. doi: 10.1016/S0002-9343(98)00190-9.
   PubMed Web of Science ®Google Scholar
• Westenfeld, R., W. Jahnen-Dechent, and M. Ketteler. 2007. Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends in Cardiovascular Medicine 17 (4):124–128. doi: 10.1016/j.tcm.2007.02.005.
   PubMed Web of Science ®Google Scholar
• Xu, Y., M. Xu, Y. Bi, A. Song, Y. Huang, Y. Liu, Y. Wu, Y. Chen, W. Wang, X. Li, and G. Ning. 2011. Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. Atherosclerosis 216 (1):180–186. doi: 10.1016/j.atherosclerosis.2011.01.020.
   PubMed Web of Science ®Google Scholar
• Yamada, S., M. Tokumoto, K. Tsuruya, N. Tatsumoto, H. Noguchi, T. Kitazono, and H. Ooboshi. 2015. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. American Journal of Physiology-Renal Physiology 309 (8):F744–F754. doi: 10.1152/ajprenal.00017.2015.
   PubMed Web of Science ®Google Scholar
• Yang, S. J., H. C. Hong, H. Y. Choi, H. J. Yoo, G. J. Cho, T. G. Hwang, S. H. Baik, D. S. Choi, S. M. Kim, and K. M. Choi. 2011. Effects of a three‐month combined exercise programme on fibroblast growth factor 21 and fetuin‐A levels and arterial stiffness in obese women. Clinical Endocrinology 75 (4):464–469. doi: 10.1111/j.1365-2265.2011.04078.x.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., and D.-Z. Zhang. 2018. Is coffee consumption associated with a lower level of serum C-reactive protein? A meta-analysis of observational studies. International Journal of Food Sciences and Nutrition 69 (8):985–994. doi: 10.1080/09637486.2018.1433640.
   PubMed Web of Science ®Google Scholar
• Zheng, S., L. de las Fuentes, A. Bierhals, R. Ash-Bernal, K. Spence, E. Slatopolsky, V. G. Davila-Roman, and J. Delmez. 2009. Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis. The American Journal of Cardiology 103 (1):46–49. doi: 10.1016/j.amjcard.2008.08.032.
   PubMed Web of Science ®Google Scholar